China Universal Asset Management Co., Ltd.
Position in AMRX — Amneal Pharmaceuticals, Inc.
CIK 1906594
SHANGHAI, F4
Position in AMRX
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$694,016
+$48,581 QoQ
Shares Held
55,834
+9.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026China Universal Asset Management Co., Ltd. holds $16,253,141 across 28 Drug Manufacturers - Specialty & Generic names. AMRX ranks #5 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
7,778 | $4,612,198 | |
| 2 | VTRS |
Viatris Inc
|
204,324 | $2,760,417 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
17,810 | $2,346,289 | |
| 4 | ALKS |
Alkermes plc.
|
29,573 | $1,045,701 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
This page
|
55,834 | $694,016 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
22,194 | $676,473 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
10,175 | $525,945 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
44,507 | $423,706 |
All Filings in AMRX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $694,016 | 55,834 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $645,435 | 51,225 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $551,080 | 55,053 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $509,257 | 62,949 | Shares | Sole | 2025-08-28 | |
| 2025-03-31 | $521,018 | 62,174 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $520,328 | 65,698 | Shares | Sole | 2025-01-24 | |
| No filing history on record for this holder in this stock. | ||||||